Concepedia

Terry W. Moore

TW

37

Publications

1.5K

Citations

23

H-Index

2006

Active since

Affiliations

University of Illinois Chicago(Current)

Emory University

University of Illinois Urbana-Champaign

University of Dundee

Johns Hopkins University

Terry W. Moore is an author at University of Illinois Chicago specializing in medicine, pharmacology, and natural sciences.

ORCID

Top concepts

Publications per year

2006–2024

37

Publications

37

Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties

Anlys Olivera, Terry W. Moore, Fang Hu et al. · International Immunopharmacology · 2011 · 215 citations · Full text

, , +8

Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism

Yuta Horie, Takafumi Suzuki, Jin Inoue et al. · Communications Biology · 2021 · 162 citations · Full text

Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators

Atul D. Jain, Haranatha R. Potteti, Benjamin G. Richardson et al. · European Journal of Medicinal Chemistry · 2015 · 104 citations · Full text

, , +1

Stapled Peptides with γ‐Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction

Thomas E. Speltz, Sean W. Fanning, Christopher G. Mayne et al. · Angewandte Chemie International Edition · 2016 · 90 citations · Full text

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

Rui Xiong, Hitisha Patel, Lauren M. Gutgesell et al. · Journal of Medicinal Chemistry · 2015 · 60 citations · Full text

Rows per page

1–5 of 37